The bilingual publisher spent years explaining Asian biotech to the world. Then it packaged the map behind the reporting into BIODND - an AI-assisted database built for the people hunting companies, capital and partners.
An AI-assisted clue helped repurpose an arthritis drug for COVID-19. A failed efficacy test, a stock-market exit and a new intelligence product show how much work comes after the discovery.